Step-change in antibody discovery process delivered by Bürkert
Advances in medical diagnosis and treatment are constantly evolving but developing a new procedure into a commercial, scalable process can be a lengthy and challenging journey. Bürkert Fluid Control Systems has applied its expertise in microfluidics to deliver a crucial component that will enable antibody biotherapeutics to be identified and isolated much more efficiently.